VivoSeq
Other

Local Anesthetic

0

Pipeline Programs

11

Active Trials

1

Companies Involved

Local Anesthetic is an early-stage landscape with 0 programs across 1 company. The most active players are American Genomics, LLC.

Pipeline Metrics

Competitive Density

28/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

90/100

Attrition Rate

8/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

103

clinical trials

Completed72 · 70%
Unknown status12 · 12%
Terminated5 · 5%
Recruiting5 · 5%
Withdrawn3 · 3%
Not yet recruiting3 · 3%
Other3 · 3%

Trial Activity

103 trials

Intralipid® 20% for Reversal of Local Anesthetics
Active, not recruiting·HHospital for Special Surgery, New York·Phase 4·NCT03968822·18 enrolled
Local Anesthetic for Plateau Fractures
Not yet recruiting·UUniversity of Washington·Phase 4·NCT06474949·100 enrolled
Page 1 of 7

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)